Hematology


Multi-Omics Approach Guides Relapsed Multiple Myeloma Treatment
Many patients with relapsed multiple myeloma are not often matched with correct treatment options in a timely or personalized manner, and most patients have a median survival rate of six years. With standard diagnosis and treatment, relapses are usually inevitable and fatal for most patients. More...30 Aug 2018

Coagulation Tests Affected by Sodium Citrate Concentration
Despite a high degree of standardization, coagulation tests largely depend on preanalytic factors. Apart from artifacts acquired during blood drawing and transportation, the in vitro anticoagulant used has a potential impact on the coagulation test result. More...27 Aug 2018

Mutations Identified As Cause for Rare Bone Marrow Disorder
Scientists have helped solve a decades-old mystery about which mutations are responsible for an inherited bone marrow disorder. The answer may allow some children to avoid the risk and expense of bone marrow transplantation, a common treatment for leukemia and bone marrow disorders. More...09 Aug 2018

Homogeneous BTK Occupancy Assay Developed
Bruton’s tyrosine kinase (BTK), a member of the tyrosine kinase expressed in the hepatocellular carcinoma (TEC) family of cytoplasmic protein tyrosine kinases, was initially identified as the pathogenic protein in X-linked agammaglobulinemia, a human primary immune deficiency disease. More...02 Aug 2018

Acute Myeloid Leukemia Risk Predicted in Healthy Individuals
The incidence of acute myeloid leukemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow failure. More...25 Jul 2018

Hematological Parameters Predict Severity of Acute Pancreatitis
Acute pancreatitis (AP) is an acute inflammation of the pancreatic parenchyma induced by activated pancreatic enzymes due to multiple causes. Current severity scores include multiple variables and some of them are only complete within 48 hours of admission. More...23 Jul 2018
In Other News
FDA Recommends Pooled Blood Testing of Zika Screening
Biochemical Changes in Stored Donor Units Analyzed
Two Viral Blood Screening Assays Get FDA Clearance
Variant CJD Diagnosed by Protein Misfolding Amplification
Testing Device Integrates Robotic Phlebotomy with Sample Processing
Novel Device Contributes to Positive Phlebotomy Experience
NIV Test Developed for Fetal Rhesus Factor
Sequencing Enables Precise Match for Blood Transfusions
Blood Type Linked to Severity of Diarrhea
Early Sepsis Indicator Alerts Emergency Department Clinicians
Molecular Tests Equivalent to Bone Marrow Analysis for MM
Chip-Based Blood Test Developed for Multiple Myeloma
Smartphone Microscopes Transformed into Lab Devices
Flow Cytometry Technique Assessed for Signaling Pathways
Chronic Fatigue Syndrome Linked to Thyroid Levels
Unusual Blood Clots Characterized in Leprosy Patients
Flow Cytometry Detects Myelodysplasia in Peripheral Blood
Telomere Length Test Influences Treatment Decisions
Multiple Myeloma Risk Genes Revealed
Blood Test Helps Identify CV Patients Most at Risk
Residual Disease in Leukemia Patients Identified by ddPCR
New Blood Draw Device Evaluated For Hemolysis
Tumor Suppressor Gene Variants Identified for Leukemia Patients
The Hematology channel at LabMedica covers the all aspect of plasma, coagulation, transfusion medicine, and blood banking, as well as related lab tools and techniques.







